These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 7333059

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Novel galactose single point method as a measure of residual liver function: example of cefoperazone kinetics in patients with liver cirrhosis.
    Hu OY, Tang HS, Chang CL.
    J Clin Pharmacol; 1995 Mar; 35(3):250-8. PubMed ID: 7608313
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosis.
    Hayton WL, Kneer J, Blouin RA, Stoeckel K.
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1318-22. PubMed ID: 2386364
    [Abstract] [Full Text] [Related]

  • 25. The rhesus monkey as a model for studies of pregnancy induced changes in metoprolol metabolism.
    Högstedt S, Lindberg BS, Regårdh CG, Moström U, Rane A.
    Pharmacol Toxicol; 1990 Jan; 66(1):32-6. PubMed ID: 2308905
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis.
    Schwartz S, Brater DC, Pound D, Green PK, Kramer WG, Rudy D.
    Clin Pharmacol Ther; 1993 Jul; 54(1):90-7. PubMed ID: 8330470
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetic interaction between verapamil and metoprolol in the dog. Stereochemical aspects.
    Murthy SS, Nelson WL, Shen DD, Power JM, Cahill CM, McLean AJ.
    Drug Metab Dispos; 1991 Jul; 19(6):1093-100. PubMed ID: 1687016
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics of promazine in patients with hepatic cirrhosis--correlation with a novel galactose single point method.
    Hu OY, Tang HS, Sheeng TY, Chen TC, Curry SH.
    J Pharm Sci; 1995 Jan; 84(1):111-4. PubMed ID: 7714731
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Bioavailability and elimination of nitrendipine in liver disease.
    Dylewicz P, Kirch W, Santos SR, Hutt HJ, Mönig H, Ohnhaus EE.
    Eur J Clin Pharmacol; 1987 Jan; 32(6):563-8. PubMed ID: 3653225
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Oxmetidine (SK&F 92994): pharmacokinetic study in patients with in patients with liver cirrhosis.
    Miglio F, Baraldini M, Serra S, Facchini A, Stefanini GF, Meliconi R, Gasbarrini G, Labo' G.
    Int J Clin Pharmacol Res; 1985 Jan; 5(6):399-404. PubMed ID: 2869000
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.